Phage Australia

Phage Australia

A national network of phage researchers and clinician scientists who aim to professionalise phage therapy as the third major intervention for infectious diseases.
16+
Patients treated
75+
Investigators and Partners
16+
Treatment Sites
2306
Registered phages
5396
Registered strains
Dhanvi cover

Our journey to treating Dhanvi

In 2019, 7-year-old Dhanvi was in a car accident. The bones in her legs became infected with bacteria. Antibiotics didn't help, and she faced amputation

Read about Dhanvi →

How does phage therapy work?

If the right phage can be found in time, phages can be used like antibiotics to cure life-threatening bacterial infections

How does it work? →

3D phage rendering

Our approach to phage therapy

How we’re tackling phage therapy’s decades-long paradox using a personalised clinical trial

Our approach →

WIMR aerial shot

Join our Network

Are you at a hospital in Australia? Are you with a patient advocate group? Do you run a phage lab, even outside of Australia? We’d still love to work with you.

Biobank

Explore the Phage Australia biobank
Register your Biobank
We are now ready to register all Phage Australia node biobanks!
Registering your phages and bacterial strains speeds up our phage therapy efforts.

Iredell Lab

Lab Name
Iredell Lab
URL
https://criticalinfection.com/
Contact Name
Jan Zheng
Contact Email
biobank@phageaustralia.org
Organization
Westmead Institute for Medical Research
City
Sydney
State
NSW
Registered Strains: 5396
Strain genera: Achromobacter (2), Acinetobacter (103), Aeromonas (4), Chryseobacterium (2), Citrobacter (231), Cupriavidus (1), Cupriviadus (1), Edwardsiella (1), Elizabethkingia (1), Enterobacter (837), Enterococcus (21), Escherichia (2477), Hafnia (7), Klebsiella (1106), Kluyvera (3), Morganella (26), Pantoea (3), Proteus (49), Providencia (4), Pseudomonas (316), Raoultella (1), Salmonella (9), Serratia (117), Shigella (26), Staphylococcus (43), Stenotrophomonas (4)
Registered Phages: 342
Phage host genera: Enterococcus (7), Escherichia (85), Klebsiella (48), Pseudomonas (30), Staphylococcus (47)
View Registered Phages (342)
View Registered Strains (5396)

The Bacteriophage Bank of Korea

Lab Name
The Bacteriophage Bank of Korea
URL
http://www.phagebank.or.kr/intro/eng_intro.jsp
Contact Name
Heejoon Myung
Contact Email
phagebank@lysentech.com
Organization
Lysentech, Hankuk Univsersity of Foreign Studies
State
Korea
Registered Strains: 0
Strain genera:
Registered Phages: 1964
Phage host genera: Acinetobacter (118), Campylobacter (102), Cronobacter (86), Enterobacter (199), Enterococcus (19), Escherichia (357), Klebsiella (102), Lactobacilus (7), Pectobacterium (1), Pseudomonas (249), Salmonella (229), Serratia (25), Shigella (107), Staphylococcus (8), salmonella (273), shigella (82)
View Registered Phages (1964)
View Registered Strains (0)

Articles

In the news

News | August 31, 2022
Phage Therapy
Academics plan to roll out therapy widely in Australia: Researchers at the University of Sydney, Western Sydney Local Health District and the Westmead Institute for Medical Research are developing a therapeutic solution to antimicrobial resistance that predates the discovery and wide usage of antibiotics…
News | August 17, 2022
Phage Therapy
An expert team, led by Director of the Centre of Infectious Diseases and Microbiology at the Westmead Institute for Medical Research (WIMR) Professor Jon Iredell, is developing a key alternative to antibiotics and central to the treatment are phages…
Twitter | July 15, 2022
Phage Therapy
Twitter | July 05, 2022
FundingPhage Therapy
Publication | June, 2022
News | June 17, 2022 | Phage WA
Leading the fight against Antimicrobial Resistance (AMR) in Western Australia: The WA Phage website showcases the research journey and outputs of WA researchers from the Wal-yan Respiratory Research Centre at the Telethon Kids Institute. The Phage WA website connects us with our community and provides up to date information on our collective mission to tackle anti-microbial resistance (AMR) through phage therapy.
Publication | 2020
Phage TherapyClinical trialSepsis
Publication | February, 2021
Publication | January, 2020
AbstractPhage Therapy
Publication | January, 2021
AcinetobacterPhage-resistanceResearch paper
Publication | March, 2020
Phage isolationKlebsiellaPhage TherapyResearch paper
Publication | May, 2021
Publication | September, 2021
Publication | April, 2021
Phage biobankOpinion paper
Publication | November, 2020
PediatricsPhage TherapyClinical trialResearch paper
Publication | March, 2019
Phage TherapyResearch paper
Publication | May, 2021
Publication | May, 2021
Publication | July, 2020
Publication | September, 2021
Review paperRespiratory Tract infectionsPhage Therapy
Publication | August, 2021
Clinical trialPediatricsImmune responsePhage Therapy
Publication | December, 2020
Phage VirulenceAntibiotic synergyResearch paper
Publication | June, 2020
Cystic FibrosisPhage isolationPseudomonasStaphylococcusPediatrics

Who we are

We are a network of clinicians, researchers, microbiologists, and engineers passionate about tackling the next existential threat to humanity

© 2022 Phage Australia
svelte head: Phage Australia